Cargando…
Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
Bardet–Biedl syndrome (BBS) is a rare genetic condition, characterized by ciliary protein dysfunction, leading to multi‐organ damage. People with BBS can develop early‐onset severe obesity and associated problems including the metabolic syndrome, type 2 diabetes and coronary heart disease. Weight ma...
Autores principales: | Ganawa, Shawg, Santhosh, Smrithi Hema, Parry, Lucy, Syed, Akheel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539684/ https://www.ncbi.nlm.nih.gov/pubmed/35932204 http://dx.doi.org/10.1111/cob.12546 |
Ejemplares similares
-
Beneficial outcomes of glucagon like peptide-1 agonist therapy in a patient with Bardet Biedl syndrome and kidney transplant
por: Erturk, Banu, et al.
Publicado: (2023) -
Bardet–Biedl Syndrome in an Ethiopian
por: Tsegaw, Asamere, et al.
Publicado: (2021) -
Bangladeshi Case Series of Bardet–Biedl Syndrome
por: Osman, Fariah, et al.
Publicado: (2023) -
Bardet-Biedl and Alström syndromes in Spain
por: Valverde, D, et al.
Publicado: (2012) -
Bardet–Biedl syndrome: beyond the cilium
por: Tobin, Jonathan L., et al.
Publicado: (2007)